← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable — 2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 2.0% below its 1-year high (as of 2026-09-17). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 8.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
GEVO
Gevo, Inc.
Valuation N/A
Basic Materials Risk 48 · Elevated
Price$1.57
Model IV—
P/IV—
Market implies +41.8%/yr vs model +5.0% · above model
GF
NEW GERMANY FUND INC
Valuation N/A
Unknown
Price$11.27
Model IV—
P/IV—
Limited data — see page
GFAI
Guardforce AI Co., Ltd.
Valuation N/A
Technology Risk 33 · Moderate
Price$0.36
Model IV—
P/IV—
Limited data — see page
GFL
GFL Environmental Inc.
Valuation N/A
Utilities
Price$42.85
Model IV—
P/IV—
Limited data — see page
GFR
Greenfire Resources Ltd.
Valuation N/A
Energy Risk 51 · Elevated
Price$6.52
Model IV—
P/IV—
Limited data — see page
GFS
GLOBALFOUNDRIES Inc.
Valuation N/A
Technology Risk 32 · Moderate
Price$46.95
Model IV—
P/IV—
Limited data — see page
GGAL
GRUPO FINANCIERO GALICIA SA
Valuation N/A
Financial Services
Price$42.14
Model IV—
P/IV—
Limited data — see page
GGB
GERDAU S.A.
Valuation N/A
Basic Materials Risk 46 · Elevated
Price$5.15
Model IV—
P/IV—
Limited data — see page
GGN
GAMCO Global Gold, Natural Resources & Income Trust
Valuation N/A
Unknown
Price$5.56
Model IV—
P/IV—
Limited data — see page
GGR
Gogoro Inc.
Valuation N/A
Consumer Cyclical Risk 42 · Elevated
Price$2.69
Model IV—
P/IV—
Limited data — see page
GGROW
Gogoro Inc.
Valuation N/A
Consumer Cyclical Risk 36 · Moderate
Price$0.01
Model IV—
P/IV—
Limited data — see page
GGT
GABELLI MULTIMEDIA TRUST INC.
Valuation N/A
Unknown
Price$4.03
Model IV—
P/IV—
Limited data — see page
GGZ
Gabelli Global Small & Mid Cap Value Trust
Valuation N/A
Unknown
Price$16.06
Model IV—
P/IV—
Limited data — see page
GHG
GreenTree Hospitality Group Ltd.
Valuation N/A
Consumer Cyclical Risk 46 · Elevated
Price$1.03
Model IV—
P/IV—
Limited data — see page
GHRS
GH Research PLC
Valuation N/A
Healthcare Risk 42 · Elevated
Price$27.20
Model IV—
P/IV—
Limited data — see page
GHY
PGIM Global High Yield Fund, Inc.
Valuation N/A
Unknown
Price$11.26
Model IV—
P/IV—
Limited data — see page
GIB
CGI INC
Valuation N/A
Industrials
Price$72.91
Model IV—
P/IV—
Limited data — see page
GIBO
GIBO HOLDINGS Ltd
Valuation N/A
Technology Risk 37 · Moderate
Price$33.54
Model IV—
P/IV—
Market implies +0.0%/yr vs model +15.0% · below model
GIL
Gildan Activewear Inc.
Valuation N/A
Consumer Cyclical Risk 37 · Moderate
Price$48.45
Model IV—
P/IV—
Limited data — see page
GITS
Global Interactive Technologies, Inc.
Valuation N/A
Technology Risk 33 · Moderate
Price$2.18
Model IV—
P/IV—
Market implies +147.0%/yr vs model +2.0% · above model
GIW
GigCapital8 Corp.
Valuation N/A
Financial Services
Price$10.16
Model IV—
P/IV—
Limited data — see page
GIWWR
GigCapital8 Corp.
Valuation N/A
Financial Services
Price$0.25
Model IV—
P/IV—
Limited data — see page
GIWWU
GigCapital8 Corp.
Valuation N/A
Financial Services
Price$10.59
Model IV—
P/IV—
Limited data — see page
GIX
GigCapital9 Corp.
Valuation N/A
Financial Services
Price$10.04
Model IV—
P/IV—
Limited data — see page
GIXXR
GigCapital9 Corp.
Valuation N/A
Financial Services
Price$0.28
Model IV—
P/IV—
Limited data — see page
GIXXU
GigCapital9 Corp.
Valuation N/A
Financial Services
Price$10.21
Model IV—
P/IV—
Limited data — see page
GJH
STRATS SM TRUST FOR U S CELL CORP SEC SERIES 2004 6
Valuation N/A
Financial Services
Price$9.39
Model IV—
P/IV—
Limited data — see page
GJO
STRATS SM TRUST FOR WAL-MART STORES, INC. SECURITIES, SERIES 2005-4
Valuation N/A
Financial Services
Price$24.62
Model IV—
P/IV—
Limited data — see page
GJP
STRATS(SM) TRUST FOR DOMINION RESOURCES, INC. SECURITIES, SERIES 2005-6
Valuation N/A
Financial Services
Price$24.61
Model IV—
P/IV—
Limited data — see page
GJR
STRATS(SM) Trust for Procter & Gamble Securities, Series 2006-1
Valuation N/A
Financial Services
Price$24.72
Model IV—
P/IV—
Limited data — see page
GJS
STRATS(SM) Trust for Goldman Sachs Group Securities, Series 2006-2
Valuation N/A
Financial Services
Price$23.22
Model IV—
P/IV—
Limited data — see page
GJT
STRATS(SM) Trust for Allstate Corp Securities, Series 2006-3
Valuation N/A
Financial Services
Price$23.22
Model IV—
P/IV—
Limited data — see page
GKOS
GLAUKOS Corp
Valuation N/A
Healthcare Risk 42 · Elevated
Price$171.09
Model IV—
P/IV—
Market implies +29.2%/yr vs model +14.6% · above model
GLAD
GLADSTONE CAPITAL CORP
Valuation N/A
Unknown Risk 40 · Elevated
Price$19.48
Model IV—
P/IV—
Limited data — see page
GLBS
GLOBUS MARITIME LTD
Valuation N/A
Industrials Risk 37 · Moderate
Price$3.72
Model IV—
P/IV—
Limited data — see page
GLDG
GoldMining Inc.
Valuation N/A
Basic Materials Risk 44 · Elevated
Price$1.04
Model IV—
P/IV—
Limited data — see page
GLDM
World Gold Trust
Valuation N/A
Financial Services Risk 43 · Elevated
Price$86.00
Model IV—
P/IV—
Limited data — see page
GLED
GalaxyEdge Acquisition Corp
Valuation N/A
Financial Services Risk 38 · Moderate
Price$10.02
Model IV—
P/IV—
Limited data — see page
GLMD
Galmed Pharmaceuticals Ltd.
Valuation N/A
Healthcare Risk 34 · Moderate
Price$3.84
Model IV—
P/IV—
Limited data — see page
GLND
Greenland Energy Co
Valuation N/A
Energy Risk 32 · Moderate
Price$1.22
Model IV—
P/IV—
Limited data — see page
GLNG
GOLAR LNG LTD
Valuation N/A
Industrials Risk 31 · Moderate
Price$52.89
Model IV—
P/IV—
Market implies +14.5%/yr vs model +10.9% · above model
GLNK
Grayscale Chainlink Trust ETF
Valuation N/A
Financial Services Risk 32 · Moderate
Price$10.27
Model IV—
P/IV—
Limited data — see page
GLO
Clough Global Opportunities Fund
Valuation N/A
Unknown
Price$5.62
Model IV—
P/IV—
Limited data — see page
GLOB
Globant S.A.
Valuation N/A
Technology Risk 37 · Moderate
Price$37.75
Model IV—
P/IV—
Limited data — see page
GLQ
Clough Global Equity Fund
Valuation N/A
Unknown
Price$7.92
Model IV—
P/IV—
Limited data — see page
GLSI
Greenwich LifeSciences, Inc.
Valuation N/A
Healthcare Risk 37 · Moderate
Price$16.09
Model IV—
P/IV—
Limited data — see page
GLU
GABELLI GLOBAL UTILITY & INCOME TRUST
Valuation N/A
Unknown
Price$18.95
Model IV—
P/IV—
Limited data — see page
GLUE
Monte Rosa Therapeutics, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$14.07
Model IV—
P/IV—
Market implies +25.8%/yr vs model +15.0% · above model
GLV
Clough Global Dividend & Income Fund
Valuation N/A
Unknown
Price$6.07
Model IV—
P/IV—
Limited data — see page
GMAB
GENMAB A/S
Valuation N/A
Healthcare
Price$32.47
Model IV—
P/IV—
Limited data — see page
GMEX
GMEX Robotics Corp
Valuation N/A
Consumer Cyclical Risk 28 · Moderate
Price$0.48
Model IV—
P/IV—
Market implies -15.2%/yr vs model +2.0% · below model
GMM
Global Mofy AI Ltd
Valuation N/A
Technology Risk 28 · Moderate
Price$1.97
Model IV—
P/IV—
Market implies -18.8%/yr vs model +25.0% · below model
GMRS
GMR Solutions Inc.
Valuation N/A
Industrials Risk 55 · Elevated
Price$12.78
Model IV—
P/IV—
Limited data — see page
GMTL
Guardian Metal Resources PLC
Valuation N/A
Basic Materials
Price$10.88
Model IV—
P/IV—
Limited data — see page
GNK
GENCO SHIPPING & TRADING LTD
Valuation N/A
Industrials Risk 44 · Elevated
Price$26.83
Model IV—
P/IV—
Market implies +21.3%/yr vs model -0.3% · above model
GNLN
Greenlane Holdings, Inc.
Valuation N/A
Industrials Risk 42 · Elevated
Price$2.98
Model IV—
P/IV—
Market implies +34.9%/yr vs model +2.0% · above model
GNLX
GENELUX Corp
Valuation N/A
Healthcare Risk 42 · Elevated
Price$2.49
Model IV—
P/IV—
Market implies +150.0%/yr vs model +2.0% · above model
GNPX
Genprex, Inc.
Valuation N/A
Healthcare Risk 33 · Moderate
Price$3.45
Model IV—
P/IV—
Limited data — see page
GNRC
GENERAC HOLDINGS INC.
Valuation N/A
Technology Risk 59 · Elevated
Price$176.98
Model IV—
P/IV—
Market implies +25.2%/yr vs model +7.7% · above model
GNS
Genius Group Ltd
Valuation N/A
Technology Risk 27 · Moderate
Price$0.16
Model IV—
P/IV—
Limited data — see page